Christine T. McCusker, MSc, MD, FRCP, Division Head, Pediatric Allergy and Immunology
I love cooking for my family and friends.
Hospital information
Clinical Director, Clinical Immunology Laboratory (MCH), Head of Immunology, Special Interest Section-CSACI and Research Director, Meakins-Christie Laboratories MUHC-Research Institute
Education
BSc (Honours), University of Toronto, MSc McMaster University
McMaster University
Montreal Children's Hospital, McGill University
Montreal Children's Hospital, McGill University
Research
Fundamental- Immunomodulation in allergy and asthma prevention and treatment; Clinical- C-PRIMES a Canadian registry for patients with primary immunodeficiency and HAE
Borte M, Quinti I, Soresina A, Fernández-Cruz E, Ritchie B, Steffen Schmidt D, McCusker C. Efficacy and safety of subcutaneous Vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter study. J Clin Immunol. 2011;31:952-961.
McCusker C and Warrington R. Primary Immunodeficiency. Allergy, Asthma & Clin Immunol. 2011; 7(Suppl 1):S1-11. Wang Y, Li Y, Shan J, E Fixman and McCusker C. Effective treatment of experimental ragweed-induced asthma with STAT-6-IP, a topically delivered cell penetrating peptide. Clin Exp Allergy. 2011;41:1622-1630.
Kaufman G, Audusseau S, Banville-Langelier A, Amir Hossein Massoud A, Wang Y, Guay J, Garellek J, Kanevsky J, Hajoui O, McCusker C, and Mazer B. Intravenous immune globulin attenuates airway hyper-responsiveness in a murine model of allergic asthma. Clin Exp Allergy. 2011;41 :718-28.